PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-7.84%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.4B
AUM Growth
+$1.4B
(-8.8%)
Cap. Flow
+$76.5M
Cap. Flow
% of AUM
5.45%
Top 10 Holdings %
Top 10 Hldgs %
48.29%
Holding
242
New
48
Increased
30
Reduced
52
Closed
51
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$32.5M |
| 2 |
Aclaris Therapeutics
ACRS
|
$22.5M |
| 3 |
Galapagos
GLPG
|
$20.6M |
| 4 |
Amicus Therapeutics
FOLD
|
$15.8M |
| 5 |
ANI Pharmaceuticals
ANIP
|
$15.5M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$17.2M |
| 2 |
DexCom
DXCM
|
$15.7M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$13.5M |
| 4 |
Assertio
ASRT
|
$13.4M |
| 5 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$12.4M |
Sector Composition
| 1 | Healthcare | 94.07% |
| 2 | Consumer Discretionary | 0.07% |
| 3 | Industrials | 0.05% |
| 4 | Energy | 0.02% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Talphera
TLPH
$11.1M
| $14.1M | 1% |
5,408,728
| – | – |
|
|
QTNT
27
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $13.8M | 0.98% |
2,854,486
+182,692
| +7% | +$884K |
|
|
ACOR
28
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $13.5M | 0.96% |
+720,000
| New | +$13.5M |
|
|
ZYNE
29
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $13.1M | 0.93% |
842,128
-26,769
| -3% | -$417K |
|
|
KDMN
30
DELISTED
Kadmon Holdings, Inc.
KDMN
| $11.8M | 0.84% |
2,209,657
| – | – |
|
31
iRhythm Technologies
IRTC
$5.5B
| $10.6M | 0.75% |
+352,241
| New | +$10.6M |
|
32
Corbus Pharmaceuticals
CRBP
$115M
| $10.6M | 0.75% |
1,250,000
-1,451,023
| -54% | -$12.3M |
|
33
Aldeyra Therapeutics
ALDX
$345M
| $10.4M | 0.74% |
1,940,458
| – | – |
|
34
CytomX Therapeutics
CTMX
$343M
| $10.2M | 0.72% |
+923,763
| New | +$10.2M |
|
|
RDUS
35
DELISTED
Radius Health, Inc.
RDUS
| $10M | 0.71% |
263,872
-49,630
| -16% | -$1.89M |
|
|
DERM
36
DELISTED
Dermira, Inc.
DERM
| $9.88M | 0.7% |
325,583
-6,027
| -2% | -$183K |
|
37
Minerva Neurosciences
NERV
$16.5M
| $9.52M | 0.68% |
810,537
| – | – |
|
|
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
| $9.15M | 0.65% |
752,999
+734,458
| +3,961% | +$8.92M |
|
39
Assembly Biosciences
ASMB
$190M
| $8.68M | 0.62% |
714,354
-63,315
| -8% | -$769K |
|
40
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.42M | 0.6% |
+1,330,240
| New | +$8.42M |
|
|
PFNX
41
DELISTED
Pfenex Inc.
PFNX
| $8.29M | 0.59% |
914,376
-25,554
| -3% | -$232K |
|
|
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.18M | 0.58% |
163,255
-3,254
| -2% | -$163K |
|
|
MYOK
43
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.09M | 0.58% |
624,694
-10,200
| -2% | -$132K |
|
44
Cidara Therapeutics
CDTX
$1.66B
| $8.04M | 0.57% |
773,369
| – | – |
|
|
ALDR
45
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $7.99M | 0.57% |
384,169
-7,111
| -2% | -$148K |
|
|
BPMC
46
DELISTED
Blueprint Medicines
BPMC
| $7.68M | 0.55% |
273,820
-186,204
| -40% | -$5.22M |
|
|
CLVS
47
DELISTED
Clovis Oncology, Inc.
CLVS
| $7.45M | 0.53% |
167,754
-3,746
| -2% | -$166K |
|
48
uniQure
QURE
$933M
| $7.09M | 0.5% |
1,265,963
-46,873
| -4% | -$262K |
|
|
ATRS
49
DELISTED
Antares Pharma, Inc.
ATRS
| $6.8M | 0.48% |
+2,917,253
| New | +$6.8M |
|
50
Clearside Biomedical
CLSD
$26.6M
| $6.37M | 0.45% |
712,062
+77,261
| +12% | +$691K |
|